Bernadette Mary Connaughton is on the board of Halozyme Therapeutics, Inc., Zealand Pharma A, Editas Medicine, Inc. and Boys & Girls Clubs of New Jersey.

In her past career Ms. Connaughton held the position of Head-European Markets, Canada & Australia at Bristol Myers Squibb Co. and President-China, Latin America & Middle East at Bristol-Myers Squibb Pharma Co. (a subsidiary of Bristol Myers Squibb Co.).

She received an undergraduate degree from The Johns Hopkins University and an MBA from The Wharton School of the University of Pennsylvania.